Context Therapeutics Appoints Dr. Karen Smith and Dr. Luke Walker to Board of Directors - Context Therapeutics ( NASDAQ:CNTX )
PHILADELPHIA, Sept. 04, 2024 ( GLOBE NEWSWIRE ) -- Context Therapeutics Inc. ( "Context" or the "Company" ) CNTX, a biopharmaceutical company advancing medicines for solid tumors, today announced the appointments of Karen Smith, MD, PhD, MBA, LLM and Luke Walker, MD, to its Board of Directors.
| Ticker |
Sentiment |
Impact |
|
CNTX
|
Somewhat Bullish
|
24 %
|
|
SGMO
|
Neutral
|
4 %
|
|
AUPH
|
Neutral
|
4 %
|
|
SKYE
|
Neutral
|
4 %
|
|
AZN
|
Neutral
|
4 %
|
|
DSSMY
|
Neutral
|
20 %
|
|
JAZZ
|
Neutral
|
4 %
|
|
ZNTL
|
Neutral
|
4 %
|
|
BMY
|
Neutral
|
4 %
|
